Positive context积极背景
Stocks股票 / Health Care / TECH
Bio-Techne · Health Care
TECH US listed · USD美股 · 美元
Bio-Techne Corporation is an American life sciences company that develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets.Bio-Techne公司是一家美国生命科学公司，为研究、诊断和生物加工市场开发、制造并销售生命科学试剂、仪器和服务。
Large cap大盘 · $11B
Health Care
Mixed profile混合特征
$72.55
Regular quote常规时段报价
-$0.07 · -0.10%
Extended quote unavailable. Showing the regular quote.盘前盘后报价暂不可用，现显示常规时段报价。
Pre-market盘前
·
52w low52周低 $41.44high高 $73.08
Leader · accounting warning — verify before buying领先 · 财务质量警示 — 买入前先核实
Daily low forming, but the bigger trend is still bearish. Small size only; stop below 72.38.日线低点正在形成，但大趋势仍偏空。只适合小仓位；止损设于 72.38 下方。
As of 2026-10-26截至 2026-10-26
Company news公司新闻
The latest reporting最新报道
One story, with the reporting behind it.将同一事件汇总，保留各来源报道。
Company intelligence公司情报
The latest call, in context把最新财报放回历史脉络
A synthesized event record across management commentary and recorded metrics. Read as context; verify exact wording in the transcript before relying.综合管理层表述与记录指标形成事件档案。仅供参考；使用前请在电话会原文中核对准确措辞。
Live company record实时公司记录
JavaScript loads the source-bounded event record here. Open Terminal if the live module does not start.JavaScript 会在此加载受来源约束的事件记录。如实时模块未启动，请打开终端。
Continue with full transcript history继续查看完整电话会历史 ↗Pressure context压力背景
History mode历史模式
Context only仅供参考 · not a signal or recommendation不构成信号或建议
Narrative claims may await line-level citation; verify in the transcript.叙述性内容可能仍待逐行引用，请在电话会原文中核对。
Price chart价格图表
daily · interactive日线 · 可交互
Open in Terminal打开终端 ↗
Loading chart…图表加载中…
The interactive chart could not load here.互动图表暂时无法在此加载。
Open the live chart in Terminal在终端中打开实时图表 ↗
Candles, volume and moving averages — pan and zoom inside the chart.蜡烛图、成交量与均线 — 图内可缩放拖动。
MMastermind Terminal — live & interactiveMastermind 终端 — 实时互动 ↗
Technicals技术面
daily bars日线数据 · 2026-10-26
Momentum (RSI 14)动量（RSI 14）
55
Neutral zone中性区域
vs 50-day average相对50日均线
+0.2% above上方
Uptrend intact趋势完好
vs 200-day average相对200日均线
+15.3% above上方
Long trend up长期向上
Volatility波动率
4th percentile第4百分位
These readings feed the stance at the top — one source per number, refreshed nightly.以上读数构成页首的引擎立场 — 每个数字只有一个来源，每晚更新。
Earnings财务业绩
next report下次财报 2026-11-0410
Estimates being raised — 3 analysts预期上调 — 3 位分析师
Mixed — beat 2 of last 4 quarters表现不稳 — 近 4 季中 2 季超预期
Post-earnings drift: +2.6% (20d)财报后漂移：+2.6%（20日）
EPS surprise vs consensus, last quarters每股收益相对预期的超预期幅度（近几个季度） · average平均 5.3%
Valuation估值
Expensive vs sector相对行业偏贵| Multiple指标 | TECH | Sector median行业中位 | Cheaper than相对便宜 |
|---|---|---|---|
| P/E (trailing)市盈率（历史） | 154.08x | 31.50 | |
| P/B市净率 | 5.62x | 3.57 | |
| P/S市销率 | 9.27x | 3.19 | |
| Earnings yield盈利收益率 | 0.65% | 2.37 | |
| FCF yield自由现金流收益率 | 2.27% | 3.88 | |
| Shareholder yield股东收益率 | 2.88% | 1.83 | |
| EV/EBITDA企业价值/EBITDA | 52.54x | 19.32 | |
| P/FCF市值/自由现金流 | 44.08x | 23.56 |
"Cheaper than" = share of sector peers trading richer on that multiple.「相对便宜」= 行业中该指标估值更高的同行占比。
Financials财务数据
fiscal years财年Revenue营业收入
$1.2B2025
20212025
5-yr growth5年复合增速 7.0%
Earnings per share每股收益
$0.462025
20212025
5-yr growth5年复合增速 -39.7%
Free cash flow自由现金流
$256.6M2025
20212025
Gross margin毛利率
64.8%
Operating margin营业利润率
8.4%
Net margin净利率
6.0%
FCF margin自由现金流利润率
23.6%
Balance-sheet quality财务体质 5/8
Bankruptcy risk: safe zone破产风险：安全区
Return on equity股本回报率 4%
Warning警示
Leverage杠杆
Net debt / EBITDA净债务/EBITDA-0.76
Current ratio流动比率3.46
Capital allocation资本配置
Stock-based comp股权薪酬$40.8M
Share count change (1y)股数变化（1年）-1.3%
Debt coming due到期债务
SEC filingsSEC 文件Its filings are available, but they do not break debt down by the year it comes due — every bucket below is unreported.已获取该公司的 SEC 文件，但文件中未按到期年度拆分债务 —— 以下各区间均未披露。
Next 12 months未来12个月
not reported未披露
Year 2第2年
not reported未披露
Year 3第3年
not reported未披露
Year 4第4年
not reported未披露
Year 5第5年
not reported未披露
After year 55年以后
not reported未披露
Not every company reports a year-by-year schedule. Nothing is being estimated in its place.并非所有公司都会披露逐年到期安排；此处不作任何估算替代。
Cash reported at 2026-06-30: $264712000.截至 2026-06-30 披露的现金：$264712000。 Operating cash flow exceeded or equaled equipment spending over 2025-07-01 to 2026-06-30; no cash burn to measure.在 2025-07-01 至 2026-06-30 期间，经营现金流不低于设备支出，无可衡量的现金消耗。
Capital-need coverage is partial; incomplete or incompatible filing inputs are not combined.资本需求覆盖信息不完整；不会合并不完整或不兼容的报告数据。
Any available cash-flow scenario is context only. Missing or incompatible inputs are not replaced with zero or a financing forecast.可用现金流情景仅供参考；缺失或不兼容的输入不以零值或融资预测替代。
Sources and cash-flow calculation来源与现金流计算
Annual period年度区间 2025-07-01 — 2026-06-30 · USD · 10-K · 0001104659-26-100322 · Filed提交日期 2026-08-24.
Cache acquired缓存获取时间: 2026-10-03T08:39:13.756576+00:00 · Evaluated as of评估截至 2026-10-26.
- Reported operating cash flow已披露经营活动现金流: $292073000
- Reported equipment spending (capex outflow)已披露设备支出（资本开支流出）: $28850000
- Derived free cash flow (operating cash flow minus capex)计算所得自由现金流（经营现金流减资本开支）: $263223000
Cash is the reported balance at period end. The runway scenario holds this annual cash-flow pace constant and excludes debt payments, restricted-cash adjustments and future financing.现金为期末已披露余额。现金跑道情景假设本年度现金流速度保持不变，不包括债务偿还、受限现金调整与未来融资。
Research context only — reported figures from SEC filings, not a rating, a signal or investment advice.仅供研究参考 — 数据摘自 SEC 文件披露口径，不构成评级、信号或投资建议。
Why is it moving为何波动
6 checks · nightly六项检查 · 每晚
Sector / Theme行业/主题
Health Care (Equal-Weight) theme — #4 of 49 themes「医疗保健（等权）」主题 — 49 个主题中第 4 位
Macro宏观
Long-duration name into a restrictive, rising-real-rate regime → rate headwind.长久期标的进入偏紧、实际利率上行的环境→利率逆风。
Positioning持仓
Short interest changed +11.4%空头仓位变动 +11.4%
Technical技术面
TECH made a new 52-week highTECH 创52周新高
Ownership & smart money持仓与聪明钱
13FInsider activity:内部人动向： -$0.3M net (0 buyers, 1 sellers)-$0.3M 净值（0 买家，1 卖家）
Concentrated ownership集中持仓
| Fund基金 | Grade评级 | Latest move最新动作 | % of book组合占比 | As of截至 |
|---|---|---|---|---|
| Soros Fund Management | B | New position新建仓 | 0.6% | 2026-06-30 |
| Durable Capital Partners | B | trimtrim | 0.3% | 2026-06-30 |
Signal history信号历史
engine events引擎事件
NEARING A HIGH → UNCONFIRMED TURN接近高点 → 未确认转向
HIGH-RISK · NIMBLE ONLY. A daily bottoming setup is forming (swing low in, momentum turned up) — but the higher timeframes haven't confirmed it: the bigger picture is still bearish (weekly momentum just crossed down). This is an UNCONFIRMED TURN, not a confirmed buy. Weekly confirmation lags price, so this exact reading covers BOTH bounces that fail AND the first leg of a genuine new cycle — you can't tell which in real time, so treat it as a risk/size signal, not a direction call. Measured: weekly-unconfirmed bottoming setups held the low ~49% of the time vs ~68% once the weekly turns up高风险 · 仅限灵活操作。正在形成日线筑底形态（摆动低点已现、动量转向上行）——但更高周期尚未确认：大局仍偏空（周线动量刚刚向下交叉）。这是「未确认转向」，并非已确认的买入。周线确认滞后于价格，因此同样的读数既涵盖最终失败的反弹，也涵盖真正新周期的第一段——实时无法判定属于哪一种，故应将其视为风险/仓位信号，而非方向判断。实测：周线未确认的筑底形态约 49% 守住低点，周线转向后升至约 68%
Oct 20, 2026
TECH made a new 52-week highTECH 创52周新高
Price reached a fresh 52-week high — a momentum / trend extreme the whole market watches. $72.58.价格创出52周新高 — 全市场关注的动量/趋势极值。$72.58。
Oct 19, 2026
NEARING A HIGH → UNCONFIRMED TURN接近高点 → 未确认转向
HIGH-RISK · NIMBLE ONLY高风险 · 仅限灵活操作
Oct 16, 2026
TECH made a new 52-week highTECH 创52周新高
Price reached a fresh 52-week high — a momentum / trend extreme the whole market watches. $72.57.价格创出52周新高 — 全市场关注的动量/趋势极值。$72.57。
Oct 16, 2026
TECH StochRSI turned up from oversoldTECH StochRSI自超卖区上行
StochRSI popped back above 20 — the earliest oscillator heads-up that downside momentum is easing. $72.57.StochRSI重回20上方 — 下行动量趋缓的最早预警。$72.57。
Oct 12, 2026
UNCONFIRMED TURN → NEARING A HIGH未确认转向 → 接近高点
TAKE PROFITS止盈
Oct 12, 2026
TECH made a new 52-week highTECH 创52周新高
Price reached a fresh 52-week high — a momentum / trend extreme the whole market watches. $72.56.价格创出52周新高 — 全市场关注的动量/趋势极值。$72.56。
Oct 9, 2026
TECH weekly MACD crossed downTECH 周线MACD下穿
The weekly MACD histogram turned negative — the slower, less-whippy momentum read.周线MACD柱状图转负 — 更慢、更少来回的动量信号。
Oct 8, 2026
NEARING A HIGH → UNCONFIRMED TURN接近高点 → 未确认转向
HIGH-RISK · NIMBLE ONLY高风险 · 仅限灵活操作
Oct 7, 2026
TECH StochRSI turned up from oversoldTECH StochRSI自超卖区上行
StochRSI popped back above 20 — the earliest oscillator heads-up that downside momentum is easing. $72.53.StochRSI重回20上方 — 下行动量趋缓的最早预警。$72.53。
Showing the last 15 of显示最近15条，共 136 signals条信号
Company profile公司档案
Bio-Techne Corporation is an American life sciences company that develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets.Bio-Techne公司是一家美国生命科学公司，为研究、诊断和生物加工市场开发、制造并销售生命科学试剂、仪器和服务。
Style DNA — how it trades vs the market风格基因 — 相对市场的交易特征
Value价值
Below market低于市场
Profitability盈利能力
Below market低于市场
Quality质量
Below market低于市场
Investment资本投入
Above market高于市场
Shareholder payout股东回报
Below market低于市场
Low volatility低波动
Below market低于市场
Low market beta低市场敏感度
Below market低于市场
Earnings quality盈利质量
Below market低于市场
Short interest空头兴趣
Below market低于市场
Watch items — what could change the story关注项 — 可能改变故事的因素
- Margin compression despite revenue growth
The whole US universe — S&P 1500 and Russell 2000 — read nightly.覆盖标普1500与罗素2000全部成分股 — 每晚更新解读。
Signals, options positioning, smart-money moves and factor DNA — the same engine that wrote this page covers 2,700+ US stocks.信号、期权持仓、聪明钱动向与因子基因 — 撰写本页的引擎覆盖2700多只美股。
Statistics — full detail统计数据 — 完整明细
Valuation vs sector估值对比行业
| Multiple指标 | This stock本股 | Sector median行业中位 | Cheaper than相对便宜 |
|---|---|---|---|
| P/E (trailing)市盈率（静态） | 154.1× | 31.5× | 4% |
| Price / Book市净率 | 5.6× | 3.6× | 31% |
| Price / Sales市销率 | 9.3× | 3.2× | 14% |
| EV / EBITDAEV/EBITDA | 52.5× | 19.3× | 9% |
| Earnings yield盈利收益率 | 0.7% | 2.4% | 28% |
| Free-cash-flow yield自由现金流收益率 | 2.5% | 5.2% | 21% |
| Shareholder yield股东综合回报率 | 2.9% | 1.8% | 68% |
Relative strength相对强度
vs market, 1 month相对大盘（1个月）
79/100 — stronger than most强于多数
vs market, 3 months相对大盘（3个月）
61/100 — middle of the pack居中
vs market, 6 months相对大盘（6个月）
88/100 — stronger than most强于多数
vs market, 12 months相对大盘（12个月）
60/100 — middle of the pack居中
Rank in sector行业内排名
#87 / 175
0–100 percentile of total return vs all covered stocks.总回报在全部覆盖股票中的百分位（0–100）。
Price history价格历史
| Period周期 | This stock本股 | S&P 500标普500 |
|---|---|---|
| 1 Week近1周 | +-0.0% | -0.4% |
| 1 Month近1月 | +0.0% | -1.0% |
| 3 Months近3月 | +1.3% | +3.1% |
| 6 Months近6月 | +34.1% | +7.0% |
| Year to date年初至今 | +22.0% | +12.1% |
| 1 Year近1年 | +10.3% | +14.4% |
Trading information交易信息
Beta vs market贝塔
0.84
Volatility rank波动率分位
4th pctile
Short interest空头占比
4.7% of float
Market cap市值
$11B
EPS (trailing)每股收益
$0.47
Off 52-week high距52周高点
-0.1%
Research context only — refreshed nightly. Not investment advice.仅供研究参考 — 每晚更新，不构成投资建议。
Financials — full detail财务数据 — 完整明细
Multi-year record多年财务记录
| 20212021 | 20222022 | 20232023 | 20242024 | 20252025 | |
|---|---|---|---|---|---|
| Revenue营业收入 | $931M | $1.1B | $1.1B | $1.2B | $1.2B |
| EPS每股收益 | $3.47 | $6.63 | $1.76 | $1.05 | $0.46 |
| Free cash flow自由现金流 | $308M | $280M | $216M | $236M | $257M |
| Gross margin毛利率 | 68.0% | 68.4% | 67.7% | 66.4% | 64.8% |
| Net margin净利率 | 15.1% | 24.6% | 25.1% | 14.5% | 6.0% |
| FCF margin自由现金流利润率 | 33.1% | 25.4% | 19.0% | 20.4% | 21.0% |
Latest fiscal year最近财年
Revenue (FY)营业收入（财年）
$1.2B
Gross profit毛利润
$790M
Net income净利润
$73M
Operating cash flow经营现金流
$288M
Total assets总资产
$2.5B
Shareholder equity股东权益
$2.0B
Dividends paid股息支出
$50M
Buybacks股票回购
$276M
Shares outstanding总股本
0.16B
Returns & growth回报与增长
Return on equity股本回报率
3.6%
Return on assets资产回报率
2.9%
Profit growth利润增速
-56.3%
Asset growth资产增速
-5.5%
Accounting quality checks会计质量检查
- Earnings quality: earnings cash-backed盈利质量：盈利有现金支撑
- Working capital: inventory +62% vs sales +31% — inventory building, demand risk营运资本：存货 +62% 对销售 +31%——存货积压，需求风险
- Pricing power: gross margin −3.2pts over 5 years定价能力：毛利率 5 年下降 3.2 个百分点
- Capital discipline: share count +297.8% over 5 years (dilution)资本纪律：股本 5 年增加 297.8%（稀释）
- Balance sheet: Altman Z 12.01 — safe zone资产负债表：Altman Z 12.01——安全区
Research context only — refreshed nightly. Not investment advice.仅供研究参考 — 每晚更新，不构成投资建议。
Technicals — full detail技术面 — 完整明细
Indicator readings指标读数
RSI (14-day)RSI（14日）
55
RSI (2-day)RSI（2日）
25
vs 20-day average相对20日均线
+0.1%
vs 50-day average相对50日均线
+0.2%
vs 200-day average相对200日均线
+15.3%
Golden cross (50>200)金叉（50>200）
in effect生效中
MACDMACD
below signal位于信号线下方
Timeframe alignment多周期共振
Daily日线
momentum down动能向下
3-day3日线
momentum down动能向下
Weekly周线
momentum down — fresh downturn动能向下——刚刚转弱
When daily through monthly point the same way, moves carry further.当日线到月线方向一致时，行情往往更有延续性。
Volatility regime波动状态
Range state波幅状态
CoiledCOILED
Days compressed已压缩天数
65
Range width percentile波幅宽度分位
3/100
Research context only — refreshed nightly. Not investment advice.仅供研究参考 — 每晚更新，不构成投资建议。
Earnings — full detail财务业绩 — 完整明细
Surprise history超预期历史
| Quarter季度 | Reported实际 | Expected预期 | Surprise超预期 |
|---|---|---|---|
| Jun 2026 | $0.49 | $0.46 | +6.5% |
| Mar 2026 | $0.48 | $0.48 | 0.0% |
| Dec 2025 | $0.39 | $0.34 | +14.7% |
| Sep 2025 | $0.36 | $0.36 | 0.0% |
Estimate revisions预期修正
Analysts covering覆盖分析师
3
Estimate direction预期调整方向
mostly raising多数上调
Estimate change, 90 days预期变化（90天）
+0.6%
Net upgrades, 30 days净上调（30天）
+3
Research context only — refreshed nightly. Not investment advice.仅供研究参考 — 每晚更新，不构成投资建议。
Ownership — full detail持仓 — 完整明细
Tracked funds holding it跟踪基金持仓
| Fund基金 | Grade评级 | Latest move最新动作 | % of book组合占比 | Position市值 |
|---|---|---|---|---|
| Soros Fund Management | B | New position新建仓 | 0.6% | $38M |
| Durable Capital Partners | B | Trimming减持 | 0.3% | $35M |
Fund positioning基金持仓概览
Tracked funds in the name持有该股的跟踪基金
2
Buying vs selling买入vs卖出
1 : 1
Quarterly trend季度趋势
{'direction': 'accumulating', 'n_quarters': 10, 'holders_first': 1, 'holders_last': 1, 'holders_delta': 0, 'value_change_pct': 13383.6, 'from_period': '2023-12-31', 'to_period': '2026-03-31', 'available_on': '2026-05-16', 'available_on_first': '2024-02-13', 'holders_series': [1, 1, 1, 1, 1, 1, 0, 1, 1, 1]}{'direction': 'accumulating', 'n_quarters': 10, 'holders_first': 1, 'holders_last': 1, 'holders_delta': 0, 'value_change_pct': 13383.6, 'from_period': '2023-12-31', 'to_period': '2026-03-31', 'available_on': '2026-05-16', 'available_on_first': '2024-02-13', 'holders_series': [1, 1, 1, 1, 1, 1, 0, 1, 1, 1]}
Insiders & shorts内部人与空头
Insider net buying (6 months)内部人净买入（6个月）
-$0.3M
Insider buyers vs sellers内部人买家vs卖家
0 : 1
Short interest空头占流通盘
4.7%
Days to cover回补天数
2.1
Short interest change空头变化
+11.4%
Recent fund flows近期基金流向
VanEck BiotechVanEck Biotech
trimming减持
Research context only — refreshed nightly. Not investment advice.仅供研究参考 — 每晚更新，不构成投资建议。